Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lipocine Return on Tangible Equity 2012-2025 | LPCN

Current and historical return on tangible equity values for Lipocine (LPCN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Lipocine Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-06-30 $0.00B $0.02B -21.05%
2025-03-31 $-0.01B $0.02B -25.00%
2024-12-31 $0.00B $0.02B 4.71%
2024-09-30 $0.00B $0.02B -14.29%
2024-06-30 $-0.01B $0.02B -36.78%
2024-03-31 $-0.01B $0.02B -37.89%
2023-12-31 $-0.02B $0.02B -66.02%
2023-09-30 $-0.02B $0.02B -57.14%
2023-06-30 $-0.01B $0.03B -35.56%
2023-03-31 $-0.01B $0.03B -30.14%
2022-12-31 $-0.01B $0.04B -25.64%
2022-09-30 $0.00B $0.04B 12.05%
2022-06-30 $0.00B $0.04B 9.94%
2022-03-31 $0.00B $0.04B 0.00%
2021-12-31 $0.00B $0.05B 0.00%
2021-09-30 $-0.02B $0.03B -57.14%
2021-06-30 $-0.02B $0.04B -70.37%
2021-03-31 $-0.02B $0.04B -84.71%
2020-12-31 $-0.02B $0.02B -168.00%
2020-09-30 $-0.02B $0.02B -185.37%
2020-06-30 $-0.02B $0.01B -211.76%
2020-03-31 $-0.02B $0.01B -193.55%
2019-12-31 $-0.01B $0.01B -129.73%
2019-09-30 $-0.01B $0.01B -120.00%
2019-06-30 $-0.01B $0.01B -100.00%
2019-03-31 $-0.01B $0.01B -91.67%
2018-12-31 $-0.01B $0.01B -84.62%
2018-09-30 $-0.01B $0.01B -83.87%
2018-06-30 $-0.02B $0.01B -86.49%
2018-03-31 $-0.02B $0.02B -89.41%
2017-12-31 $-0.02B $0.02B -90.32%
2017-09-30 $-0.02B $0.02B -76.00%
2017-06-30 $-0.02B $0.03B -65.38%
2017-03-31 $-0.02B $0.03B -61.82%
2016-12-31 $-0.02B $0.03B -62.81%
2016-09-30 $-0.02B $0.03B -61.31%
2016-06-30 $-0.02B $0.03B -61.94%
2016-03-31 $-0.02B $0.04B -50.00%
2015-12-31 $-0.02B $0.04B -43.90%
2015-09-30 $-0.02B $0.05B -45.95%
2015-06-30 $-0.02B $0.05B -45.45%
2015-03-31 $-0.02B $0.02B -63.16%
2014-12-31 $-0.02B $0.03B -61.07%
2014-09-30 $-0.02B $0.03B -53.33%
2014-06-30 $-0.02B $0.03B -48.72%
2014-03-31 $-0.01B $0.04B -42.62%
2013-12-31 $-0.01B $0.05B -44.44%
2013-09-30 $0.00B $0.04B 0.00%
2013-06-30 $0.00B $0.00B 160.00%
2013-03-31 $0.00B $0.00B 240.00%
2012-12-31 $0.00B $0.01B 320.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.011B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.696B 26.04
Zoetis (ZTS) United States $65.303B 23.69
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
Takeda Pharmaceutical (TAK) Japan $45.947B 9.38
BeOne Medicines - (ONC) Cayman Islands $31.585B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.846B 0.00
Summit Therapeutics (SMMT) United States $21.285B 0.00
Merck (MKKGY) Germany $16.407B 10.67
Shionogi (SGIOY) Japan $15.227B 15.26
United Therapeutics (UTHR) United States $13.600B 11.77
Neurocrine Biosciences (NBIX) United States $12.399B 36.99
Orion OYJ (ORINY) Finland $10.757B 25.93
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.676B 0.00
Corcept Therapeutics (CORT) United States $7.618B 63.98
Grifols, S.A (GRFS) Spain $7.329B 0.00
Stevanato Group S.p.A (STVN) Italy $7.156B 42.20
Ionis Pharmaceuticals (IONS) United States $6.637B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.376B 0.00
Hypermarcas (HYPMY) Brazil $2.869B 21.57
NewAmsterdam Pharma (NAMS) Netherlands $2.842B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.677B 12.75
Crinetics Pharmaceuticals (CRNX) United States $2.514B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.422B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $2.274B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.742B 0.00
ARS Pharmaceuticals (SPRY) United States $1.719B 0.00
Dyne Therapeutics (DYN) United States $1.588B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.497B 22.29
Evotec AG (EVO) Germany $1.396B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Harrow (HROW) United States $1.263B 0.00
Ardelyx (ARDX) United States $1.256B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.233B 0.00
Collegium Pharmaceutical (COLL) United States $1.122B 6.01
Xeris Biopharma Holdings (XERS) United States $1.070B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.868B 0.00
ProKidney (PROK) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.681B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Siga Technologies (SIGA) United States $0.642B 7.93
Elite Pharmaceuticals (ELTP) United States $0.626B 0.00
KalVista Pharmaceuticals (KALV) United States $0.620B 0.00
Organogenesis (ORGO) United States $0.578B 0.00
Theravance Biopharma (TBPH) United States $0.576B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.569B 5.86
Bioventus (BVS) United States $0.568B 13.84
Relay Therapeutics (RLAY) United States $0.552B 0.00
Tourmaline Bio (TRML) United States $0.532B 0.00
USANA Health Sciences (USNA) United States $0.527B 10.81
Xencor (XNCR) United States $0.516B 0.00
Oruka Therapeutics (ORKA) United States $0.490B 0.00
Savara (SVRA) United States $0.456B 0.00
Aquestive Therapeutics (AQST) United States $0.387B 0.00
Esperion Therapeutics (ESPR) United States $0.371B 0.00
Nanobiotix S.A (NBTX) France $0.348B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.342B 0.00
AleAnna (ANNA) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.296B 0.00
Nektar Therapeutics (NKTR) United States $0.286B 0.00
Altimmune (ALT) United States $0.280B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 17.82
Galectin Therapeutics (GALT) United States $0.263B 0.00
4D Molecular Therapeutics (FDMT) United States $0.261B 0.00
OmniAb (OABI) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
MEI Pharma (MEIP) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.150B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.145B 22.42
Protara Therapeutics (TARA) United States $0.121B 0.00
Liminatus Pharma (LIMN) United States $0.115B 0.00
Avita Medical (RCEL) United States $0.112B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Inhibikase Therapeutics (IKT) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
VAXART, INC (VXRT) United States $0.087B 0.00
Achieve Life Sciences (ACHV) Canada $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Dominari Holdings (DOMH) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Surrozen (SRZN) United States $0.082B 0.00
Vivani Medical (VANI) United States $0.082B 0.00
Cardiol Therapeutics (CRDL) Canada $0.082B 0.00
Nutriband (NTRB) United States $0.080B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Metagenomi (MGX) United States $0.072B 0.00
BioNxt Solutions (BNXTF) Canada $0.071B 0.00
Assertio Holdings (ASRT) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Context Therapeutics (CNTX) United States $0.065B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.36
Plus Therapeutics (PSTV) United States $0.048B 0.00
Fractyl Health (GUTS) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.044B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Jupiter Neurosciences (JUNS) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
FibroGen (FGEN) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Mural Oncology (MURA) Ireland $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.36
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00